Real time insider trading transaction history:
- Insiders are prohibited from making short-swing profits by trading their shares within 6 months of the registration or acquiring the shares.
"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>
- Peter Lynch
What is insider trading>>

Common stock purchase or sale:
Transaction Date | Reported DateTime | Company | Symbol | Insider Relationship | Shares Traded | Average Price | Total Amount | Shares Owned | Filing |
2021-06-03 Purchase | 2021-06-07 5:25 pm | Cyclerion Therapeutics Inc. | CYCN | Hecht Peter M CEO | 823,170 | $3.28 | $2,699,998 | 2,049,153 (Indirect Direct) | View |
2021-05-06 Purchase | 2021-05-10 08:45 am | Cyclerion Therapeutics Inc. | CYCN | Hecht Peter M CEO | 302,000 | $2.43 | $733,860 | 1,225,983 (Indirect Direct) | View |
2021-05-04 Purchase | 2021-05-06 9:27 pm | Cyclerion Therapeutics Inc. | CYCN | Hecht Peter M CEO | 698,001 | $2.4268 | $1,693,943 | 923,983 (Indirect Direct) | View |
2019-01-23 Sale | 2019-01-25 6:24 pm | IRONWOOD PHARMACEUTICALS INC | IRWD | Hecht Peter M CEO | 89,551 | $12.53 | $1,122,209 | 4,882,365 (Indirect Direct) | View |
2017-12-06 Sale | 2017-12-08 5:00 pm | IRONWOOD PHARMACEUTICALS INC | IRWD | Hecht Peter M CEO | 113,405 | $15.12 | $1,714,515 | 4,882,277 (Indirect Direct) | View |
Stock options: Exercise, Award, Grant, Conversion
Transaction Date | Reported DateTime | Exercisable Expiration | Company | Symnbol | Insider Relationship | Shares Traded | Conversion Price | Shares Owned | Filing |
2022-01-03 Option Award | 2022-01-24 11:38 am | N/A 2032-01-03 | Cyclerion Therapeutics Inc. | CYCN | Hecht Peter M CEO | 482,950 | $0 | 482,950 (Direct) | View |
2020-03-31 Option Award | 2020-04-02 4:59 pm | N/A 2030-03-31 | Cyclerion Therapeutics Inc. | CYCN | Hecht Peter M CEO | 153,846 | $2.65 | 379,037 (Direct) | View |
2019-11-22 Option Award | 2019-11-26 5:43 pm | N/A 2029-11-22 | Cyclerion Therapeutics Inc. | CYCN | Hecht Peter M CEO | 75,000 | $0 | 75,000 (Direct) | View |
2019-04-01(A) Option Award | 2019-09-20 4:05 pm | N/A 2021-02-01 | Cyclerion Therapeutics Inc. | CYCN | Hecht Peter M CEO | 2,199,388 | $0 | 2,199,388 (Direct) | View |
2019-07-10 Exercise | 2019-07-12 4:09 pm | N/A N/A | Cyclerion Therapeutics Inc. | CYCN | Hecht Peter M CEO | 2,000 | $6.04 | 226,647 (Direct) | View |
2019-07-10 Exercise | 2019-07-12 4:09 pm | N/A 2019-07-28 | Cyclerion Therapeutics Inc. | CYCN | Hecht Peter M CEO | 2,000 | $0 | 226,647 (Direct) | View |
2019-04-01 Option Award | 2019-04-03 8:30 pm | N/A 2019-07-28 | Cyclerion Therapeutics Inc. | CYCN | Hecht Peter M CEO | 2,272,626 | $0 | 2,272,626 (Direct) | View |
2019-04-01 Disposition | 2019-04-03 6:08 pm | N/A 2019-07-28 | IRONWOOD PHARMACEUTICALS INC | IRWD | Hecht Peter M CEO | 1,921,594 | $0 | 3,213,406 (Direct) | View |
2019-03-05 Gift | 2019-03-06 6:45 pm | N/A N/A | IRONWOOD PHARMACEUTICALS INC | IRWD | Hecht Peter M CEO | 2,500,000 | $0 | 2,231,916 (Direct) | View |
2019-01-29 Option Award | 2019-01-31 5:35 pm | N/A 2029-01-29 | IRONWOOD PHARMACEUTICALS INC | IRWD | Hecht Peter M CEO | 1,000,000 | $0 | 1,000,000 (Direct) | View |
2019-01-23 Exercise | 2019-01-25 6:24 pm | N/A N/A | IRONWOOD PHARMACEUTICALS INC | IRWD | Hecht Peter M CEO | 110,000 | $4.89 | 4,882,365 (Direct) | View |
2019-01-23 Exercise | 2019-01-25 6:24 pm | N/A 2019-02-11 | IRONWOOD PHARMACEUTICALS INC | IRWD | Hecht Peter M CEO | 110,000 | $0 | 4,882,365 (Direct) | View |
2018-12-31 Other | 2019-01-03 8:06 pm | N/A 2019-02-11 | IRONWOOD PHARMACEUTICALS INC | IRWD | Hecht Peter M CEO | 4,996,917 | $0 | 14,255,301 (Direct) | View |
2018-02-21 Option Award | 2018-02-22 6:07 pm | N/A 2028-02-21 | IRONWOOD PHARMACEUTICALS INC | IRWD | Hecht Peter M CEO | 580,000 | $0 | 580,000 (Direct) | View |
2017-12-06 Exercise | 2017-12-08 5:00 pm | N/A N/A | IRONWOOD PHARMACEUTICALS INC | IRWD | Hecht Peter M CEO | 140,000 | $3.76 | 4,882,277 (Direct) | View |
2017-12-06 Exercise | 2017-12-08 5:00 pm | N/A 2018-01-31 | IRONWOOD PHARMACEUTICALS INC | IRWD | Hecht Peter M CEO | 140,000 | $0 | 4,882,277 (Direct) | View |